Genic Co. Ltd (123330) — Cash Flow-to-Debt Ratio
Genic Co. Ltd (123330) has a Cash Flow-to-Debt Ratio of 0.50x as of December 2025, meaning its operating cash flow of ₩7.70 Billion could theoretically repay 0% of its total liabilities (₩15.49 Billion) in one year. See Genic Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genic Co. Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Genic Co. Ltd across 14 annual periods. Also explore net asset momentum of Genic Co. Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Genic Co. Ltd (2012–2025)
Year-by-year debt coverage analysis for Genic Co. Ltd. For market capitalisation and broader financial context, see Genic Co. Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩20.65 Billion | ₩15.49 Billion | ▲ +7732.4% |
| 2024 | 0.02x | ₩272.46 Million | ₩16.00 Billion | ▲ +175.3% |
| 2023 | -0.02x | ₩-268.31 Million | ₩11.87 Billion | ▼ -283.1% |
| 2022 | 0.01x | ₩177.94 Million | ₩14.41 Billion | ▼ -90.3% |
| 2021 | 0.13x | ₩3.32 Billion | ₩26.11 Billion | ▲ +1561.8% |
| 2020 | 0.01x | ₩212.66 Million | ₩27.77 Billion | ▼ -82.8% |
| 2019 | 0.04x | ₩1.38 Billion | ₩31.01 Billion | ▲ +117.1% |
| 2018 | -0.26x | ₩-8.90 Billion | ₩34.37 Billion | ▼ -147.9% |
| 2017 | -0.10x | ₩-4.09 Billion | ₩39.11 Billion | ▼ -315.1% |
| 2016 | 0.05x | ₩1.93 Billion | ₩39.63 Billion | ▼ -61.2% |
| 2015 | 0.13x | ₩3.63 Billion | ₩28.97 Billion | ▼ -56.1% |
| 2014 | 0.29x | ₩5.80 Billion | ₩20.34 Billion | ▼ -9.2% |
| 2013 | 0.31x | ₩3.68 Billion | ₩11.70 Billion | ▼ -47.5% |
| 2012 | 0.60x | ₩4.31 Billion | ₩7.20 Billion | — |